학술논문
Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia
Document Type
Article
Author
Source
In: American Journal of Cardiology . (American Journal of Cardiology, 1 May 2015, 115(9):1212-1221)
Subject
Language
English
ISSN
18791913
00029149
00029149